RxDoctor Payments Data

Brian Anderson, DO

Plastic Surgery within the Head & Neck · Spartanburg, SCNPI 1689231201

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by GSK at 45.6% of the total.

$1,921in general payments, 2019–2025

Across 35 payments — averaging $54.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$876
  • Medtronic$464
  • Integra Lifesciences Corporation$164
  • Sanara Medtech Inc.$128
  • Sanofi$74
  • Aerin Medical Inc.$68
  • plus $147 from 5 others
$916in research payments, 2019–2025

Across 6 payments — averaging $152.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$916

What the payments were for

  • Food & beverage$1,921100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic surgery within the head & neck providers in South Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$48,820
Medicare patients
224
Services billed
543

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl40$1,160
Ipratropium Bromide22$483
Famotidine37$321
Fluticasone Propionate19$179
Ofloxacin11$178
Ciprofloxacin Hcl12$107
Omeprazole18$80
Prednisone21$42

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in Spartanburg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →